Braveheart Bio, Inc. (BRVE)

Braveheart Bio Statistics

Total Valuation

Braveheart Bio has a market cap or net worth of $1.67 billion. The enterprise value is $1.59 billion.

Market Cap	1.67B
Enterprise Value	1.59B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Braveheart Bio has 64.17 million shares outstanding.

Current Share Class	64.17M
Shares Outstanding	64.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.93%
Owned by Institutions (%)	n/a
Float	640,364

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	23.31
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.11, with a Debt / Equity ratio of 0.01.

Current Ratio	8.11
Quick Ratio	8.06
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-27.07%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	1,056,111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.46M
Pretax Income	-80.23M
Net Income	-80.23M
EBITDA	n/a
EBIT	-19.46M
Earnings Per Share (EPS)	-$2.63

Balance Sheet

The company has $80.58 million in cash and $667,000 in debt, with a net cash position of $79.91 million or $1.25 per share.

Cash & Cash Equivalents	80.58M
Total Debt	667,000
Net Cash	79.91M
Net Cash Per Share	$1.25
Equity (Book Value)	71.49M
Book Value Per Share	-2.57
Working Capital	71.07M

Cash Flow

In the last 12 months, operating cash flow was -$7.20 million and capital expenditures -$36,000, giving a free cash flow of -$7.24 million.

Operating Cash Flow	-7.20M
Capital Expenditures	-36,000
Depreciation & Amortization	2,000
Net Borrowing	n/a
Free Cash Flow	-7.24M
FCF Per Share	-$0.11

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Braveheart Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.81%
FCF Yield	-0.43%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial statistics are provided by S&P Global Market Intelligence. Financial numbers update within hours after each earnings release, while price-based statistics and ratios update throughout each trading day.

Update frequency:

Daily

Last checked:

Aug 13, 2026

Data Sources Report a data error